Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy

Lili Wang; Min Li; Na Zhang
January 2012
International Journal of Nanomedicine;2012, Vol. 7, p3281
Academic Journal
No abstract available.


Related Articles

  • Recent Improvements in the Use of Synthetic Peptides for a Selective Photodynamic Therapy. Schneider, Raphael; Tirand, Loraine; Frochot, Celine; Vanderesse, Regis; Thomas, Noemie; Gravier, Julien; Guillemin, Francois; Barberi-Heyob, Muriel // Anti-Cancer Agents in Medicinal Chemistry;2006, Vol. 6 Issue 5, p469 

    Photodynamic therapy (PDT) is a relatively new cytotoxic treatment, predominantly used in anti-cancer approaches, that depends on the retention of photosensitizers in tumor and their activation after light exposure. Photosensitizers are photoactive compounds such as porphyrins and chlorins that...

  • Endocyte Raises $15M As Part Of Series C Round.  // Bioworld Week;4/2/2007, Vol. 15 Issue 14, p2 

    The article reports that West Lafayette, Indiana-based Endocyte Inc. has raised $15 million in a Series C-3 round of financing to back-up the development of receptor-targeted therapeutics for cancer and autoimmune diseases treatment. The author noted that the company has raised $22.6 million in...

  • Active-Targeted Nanotherapy Strategies for Prostate Cancer. Katsogiannou, M.; Peng, L.; Catapano, C. V.; Rocchi, P. // Current Cancer Drug Targets;Oct2011, Vol. 11 Issue 8, p954 

    Castration-resistant prostate cancer remains incurable and a major cause of mortality worldwide. The absence of effective therapeutic approaches for advanced prostate cancer has led to an intensive search for novel treatments. Emerging nanomedical approaches have shown promising results, in...

  • Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide. Serpe, Loredana; Gallicchio, Margherita; Canaparo, Roberto; Dosio, Franco // Pharmacogenomics & Personalized Medicine;2014, Vol. 7, p31 

    Among the gynecological malignancies, ovarian cancer is the leading cause of mortality in developed countries. Treatment of ovarian cancer is based on surgery integrated with chemotherapy. Platinum-based drugs (cisplatin and carboplatin) comprise the core of first-line chemotherapy for patients...

  • Interobserver Agreement and Assay Reproducibility of Folate Receptor α Expression in Lung Adenocarcinoma. Bremer, Ryan E.; Scoggin, Tatiana S.; Somers, Elizabeth B.; O¨Shannessy, Daniel J.; Tacha, David E. // Archives of Pathology & Laboratory Medicine;Dec2013, Vol. 137 Issue 12, p1747 

    Context.-Lung cancer is the leading cause of cancer deaths in the United States and globally. Folate-targeted drugs are among the promising new targeted therapies for lung cancer, provided predictive biomarkers can be identified for optimal patient selection. Objective.-To evaluate the...

  • Folate-Targeted Gene Transfer in Vivo. Hofland, Hans E. J.; Masson, Christophe; Iginla, Shaff; Osetinsky, Irina; Reddy, Joseph A.; Leamon, Christopher P.; Scherman, Daniel; Bessodes, Michel; Wils, Pierre // Molecular Therapy;Jun2002, Vol. 5 Issue 6, p739 

    Nonviral systemic delivery is one of the most attractive approaches for cancer gene therapy. To achieve this goal, various laboratories have developed cationic liposomes. However, when injected intravenously, cationic lipid–DNA complexes accumulate mostly into and transfect lung tissue....

  • Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models. Gabizon, Alberto; Tzemach, Dina; Gorin, Jenny; Mak, Lidia; Amitay, Yasmine; Shmeeda, Hilary; Zalipsky, Samuel // Cancer Chemotherapy & Pharmacology;May2010, Vol. 66 Issue 1, p43 

    The folate receptor (FR) is overexpressed in a broad spectrum of malignant tumors and represents an attractive target for selective delivery of anti-cancer agents to FR-expressing tumors. Targeting liposomes to the FR has been proposed as a way to enhance the effects of liposome-based...

  • Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs. Prados, J.; Melguizo, C.; Ortiz, R.; Perazzoli, G.; Cabeza, L.; Álvarez, P. J.; Rodriguez-Serrano, F.; Aranega, A. // Anti-Cancer Agents in Medicinal Chemistry;Oct2013, Vol. 12 Issue 8, p1204 

    The number of patients with colorectal cancer, the third most frequently diagnosed malignancy in the world, has increased markedly over the past 20 years and will continue to increase in the future. Despite recent advances in chemotherapy, currently used anticancer molecules are unable to...

  • Folate-Targeted Nanoparticles Based on Albumin and Albumin/Alginate Mixtures as Controlled Release Systems of Tamoxifen: Synthesis and In Vitro Characterization. Martínez, A.; Olmo, R.; Iglesias, I.; Teijón, J.; Blanco, M. // Pharmaceutical Research;Jan2014, Vol. 31 Issue 1, p182 

    Purpose: Preparation and in vitro characterization of tamoxifen (TMX)-loaded folate-targeted nanoparticles based on disulfide bond reduced bovine serum albumin (BSA-SH) and BSA-SH/alginate-cysteine (BSA-SH/ALG-CYS) mixtures as drug delivery systems. Methods: Folate-nanoparticles were...

  • Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments. Ledermann, J. A.; Canevari, S.; Thigpen, T. // Annals of Oncology;Oct2015, Vol. 26 Issue 10, p2034 

    Background: In cancer therapy, molecularly targeted agents have the potential to maximize antitumor efficacy while minimizing treatment-related toxicity. However, these agents may only be effective in specific tumor subtypes with defined genomic profiles. This emphasizes the importance of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics